Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,082,007
-$612,729 QoQ
Shares Held
173,439
-5.8% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 329 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,026 across 296 Biotechnology names. PCVX ranks #54 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in PCVX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,082,007 | 173,439 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $10,694,736 | 184,043 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $6,515,889 | 141,220 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $6,450,494 | 179,081 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,254,782 | 161,636 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $47,420,025 | 1,255,827 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $95,453,176 | 1,166,054 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $149,933,207 | 1,312,096 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $81,454,142 | 1,078,720 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $84,329,306 | 1,234,509 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $14,252,521 | 226,951 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,726,782 | 151,565 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,892,660 | 238,139 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,479,259 | 39,468 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $10,560,459 | 220,239 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $865,200 | 36,050 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $818,088 | 37,596 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $656,613 | 27,189 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $344,240 | 14,470 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $422,612 | 16,658 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $327,812 | 14,563 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||